Sage Therapeutics SG&A Expense (Quarterly) Trends

Sage Therapeutics Inc (SAGE)

13.24 -0.70 (-5.02%) USD | NASDAQ | May 01, 16:00

13.24 0.00 (0.00%) After-Hours: 17:45

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	52.57M
December 31, 2023	55.11M
September 30, 2023	78.14M
June 30, 2023	75.49M
March 31, 2023	65.71M
December 31, 2022	67.33M
September 30, 2022	61.48M
June 30, 2022	55.55M
March 31, 2022	46.48M
December 31, 2021	51.60M
September 30, 2021	48.71M
June 30, 2021	43.35M
March 31, 2021	39.85M
December 31, 2020	53.50M
September 30, 2020	35.10M
June 30, 2020	38.22M
March 31, 2020	70.13M
December 31, 2019	85.13M
September 30, 2019	88.50M
June 30, 2019	88.23M
March 31, 2019	83.92M
December 31, 2018	75.70M

Date	Value
September 30, 2018	53.69M
June 30, 2018	43.17M
March 31, 2018	28.85M
December 31, 2017	19.56M
September 30, 2017	16.09M
June 30, 2017	14.95M
March 31, 2017	12.28M
December 31, 2016	14.37M
September 30, 2016	8.989M
June 30, 2016	8.91M
March 31, 2016	7.133M
December 31, 2015	8.236M
September 30, 2015	6.604M
June 30, 2015	6.456M
March 31, 2015	3.997M
December 31, 2014	3.416M
September 30, 2014	2.869M
June 30, 2014	1.807M
March 31, 2014	1.617M
December 31, 2013	1.203M
September 30, 2013	1.111M
June 30, 2013	0.801M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

35.10M

Minimum

Sep 2020

88.50M

Maximum

Sep 2019

60.01M

Average

55.33M

Median

SG&A Expense (Quarterly) Benchmarks